NOVAVAX INC: net current accounts receivable
Net current accounts receivable for NOVAVAX INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All NOVAVAX INC financial histories
What this measure means
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
Exact concept: us-gaap:AccountsReceivableNetCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2016-12-31. The SEC response was captured on 2026-09-19.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2016-12-31 | 233,000 | USD | 2017-02-27 | 10-K · 0001144204-17-011334 |
| At date | 2015-12-31 | 2,320,000 | USD | 2017-02-27 | 10-K · 0001144204-17-011334 |
| At date | 2014-12-31 | 7,510,000 | USD | 2016-02-29 | 10-K · 0001144204-16-084770 |
| At date | 2013-12-31 | 1,911,000 | USD | 2015-02-27 | 10-K · 0001144204-15-012379 |
| At date | 2012-12-31 | 1,011,000 | USD | 2014-03-12 | 10-K · 0001144204-14-014965 |
| At date | 2011-12-31 | 1,965,000 | USD | 2013-03-12 | 10-K · 0001144204-13-014545 |
| At date | 2010-12-31 | 54,000 | USD | 2012-03-14 | 10-K · 0001144204-12-014910 |
Related financial histories
- NOVAVAX INC: total assets
- NOVAVAX INC: total liabilities
- NOVAVAX INC: stockholders equity
- NOVAVAX INC: cash and cash equivalents
- NOVAVAX INC: net income or loss
- NOVAVAX INC: operating cash flow
- NOVAVAX INC: revenue
- NOVAVAX INC: contract revenue excluding tax
- NOVAVAX INC: financing cash flow
- NOVAVAX INC: investing cash flow
- NOVAVAX INC: retained earnings or deficit
- NOVAVAX INC: basic weighted-average shares
- NOVAVAX INC: diluted weighted-average shares
- NOVAVAX INC: basic earnings per share
- NOVAVAX INC: diluted earnings per share
- NOVAVAX INC: income tax expense or benefit
- NOVAVAX INC: net property, plant and equipment
- NOVAVAX INC: share-based compensation expense
- NOVAVAX INC: operating income or loss
- NOVAVAX INC: current assets
- NOVAVAX INC: interest expense
- NOVAVAX INC: current liabilities
- NOVAVAX INC: current accounts payable
- NOVAVAX INC: goodwill carrying amount
- NOVAVAX INC: net finite-lived intangible assets
- NOVAVAX INC: net inventory
- NOVAVAX INC: cost of revenue
- NOVAVAX INC: selling, general and administrative expense
- NOVAVAX INC: research and development expense
Inspect the source
- Entity
- NOVAVAX INC / CIK 0001000694
- Captured
- 2026-09-19T11:15:37.615Z
- SEC response SHA-256
0fb56a11efd6cc96d61f018dff603b80c35a0c72f25cb72fbb22841851b792af
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001000694.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))